Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.

Green RF, Ari M, Kolor K, Dotson WD, Bowen S, Habarta N, Rodriguez JL, Richardson LC, Khoury MJ.

Genet Med. 2019 Jan;21(1):28-37. doi: 10.1038/s41436-018-0028-2. Epub 2018 Jun 15. Review.

PMID:
29907802
2.

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.

Roberts MC, Dotson WD, DeVore CS, Bednar EM, Bowen DJ, Ganiats TG, Green RF, Hurst GM, Philp AR, Ricker CN, Sturm AC, Trepanier AM, Williams JL, Zierhut HA, Wilemon KA, Hampel H.

Health Aff (Millwood). 2018 May;37(5):801-808. doi: 10.1377/hlthaff.2017.1630. Review.

PMID:
29733730
3.

From public health genomics to precision public health: a 20-year journey.

Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, Kolor K, Rodriguez JL, Wulf A, Yu W.

Genet Med. 2018 Jun;20(6):574-582. doi: 10.1038/gim.2017.211. Epub 2017 Dec 14. Review.

4.

Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.

Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.

Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.

PMID:
28933789
5.

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.

Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.

MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.

6.

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.

Lynch JA, Berse B, Dotson WD, Khoury MJ, Coomer N, Kautter J.

Genet Med. 2017 Aug;19(8):890-899. doi: 10.1038/gim.2016.209. Epub 2017 Jan 26.

PMID:
28125086
7.

A knowledge base for tracking the impact of genomics on population health.

Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ.

Genet Med. 2016 Dec;18(12):1312-1314. doi: 10.1038/gim.2016.63. Epub 2016 Jun 9.

8.

Clinical utility of genetic and genomic services: context matters.

Dotson WD, Bowen MS, Kolor K, Khoury MJ.

Genet Med. 2016 Jul;18(7):672-4. doi: 10.1038/gim.2015.153. Epub 2015 Dec 10. No abstract available.

9.

Genomics in Public Health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC).

Green RF, Dotson WD, Bowen S, Kolor K, Khoury MJ.

Healthcare (Basel). 2015;3(3):830-7. Epub 2015 Sep 15.

10.

Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews.

Marrone M, Stewart A, Dotson WD.

Genet Med. 2015 Jul;17(7):519-32. doi: 10.1038/gim.2014.140. Epub 2014 Dec 4. Review.

11.

Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.

Parkman AA, Foland J, Anderson B, Duquette D, Sobotka H, Lynn M, Nottingham S, Dotson WD, Kolor K, Cox SL.

J Genet Couns. 2015 Jun;24(3):512-21. doi: 10.1007/s10897-014-9771-y. Epub 2014 Sep 23.

12.

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ.

Genet Med. 2015 Jan;17(1):63-7. doi: 10.1038/gim.2014.69. Epub 2014 Jun 19.

13.

Horizon scanning for translational genomic research beyond bench to bedside.

Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ.

Genet Med. 2014 Jul;16(7):535-8. doi: 10.1038/gim.2013.184. Epub 2014 Jan 9.

14.

Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ.

Clin Pharmacol Ther. 2014 Apr;95(4):394-402. doi: 10.1038/clpt.2013.226. Epub 2014 Feb 19. Review.

15.

Public health action in genomics is now needed beyond newborn screening.

Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ.

Public Health Genomics. 2012;15(6):327-34. doi: 10.1159/000341889. Epub 2012 Sep 11. Review.

16.

Knowledge integration at the center of genomic medicine.

Khoury MJ, Gwinn M, Dotson WD, Schully SD.

Genet Med. 2012 Jul;14(7):643-7.

17.

Beyond base pairs to bedside: a population perspective on how genomics can improve health.

Khoury MJ, Gwinn M, Bowen MS, Dotson WD.

Am J Public Health. 2012 Jan;102(1):34-7. doi: 10.2105/AJPH.2011.300299. Epub 2011 Nov 28.

18.

Is there a need for PGxceptionalism?

Khoury MJ, Gwinn M, Dotson WD, Bowen MS.

Genet Med. 2011 Oct;13(10):866-7. doi: 10.1097/GIM.0b013e3182265bed. No abstract available.

PMID:
21799428
19.

Horizon scanning for new genomic tests.

Gwinn M, Grossniklaus DA, Yu W, Melillo S, Wulf A, Flome J, Dotson WD, Khoury MJ.

Genet Med. 2011 Feb;13(2):161-5. doi: 10.1097/GIM.0b013e3182011661.

PMID:
21233720
20.

Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies--a targeted evidence-based review.

Palomaki GE, Melillo S, Neveux L, Douglas MP, Dotson WD, Janssens AC, Balkite EA, Bradley LA.

Genet Med. 2010 Dec;12(12):772-84. doi: 10.1097/GIM.0b013e3181f8728d. Review.

PMID:
21045709
21.

PLoS currents: evidence on genomic tests - At the crossroads of translation.

Gwinn M, Dotson WD, Khoury MJ.

PLoS Curr. 2010 Sep 2;2. pii: RRN1179. doi: 10.1371/currents.RRN1179.

22.

Tumor gene expression profiling in women with breast cancer. Test category: prognostic.

Bellcross C, Dotson WD.

PLoS Curr. 2010 Sep 2;2. pii: RRN1178. doi: 10.1371/currents.RRN1178.

23.

Outcomes of interest in evidence-based evaluations of genetic tests.

Botkin JR, Teutsch SM, Kaye CI, Hayes M, Haddow JE, Bradley LA, Szegda K, Dotson WD; EGAPP Working Group.

Genet Med. 2010 Apr;12(4):228-35. doi: 10.1097/GIM.0b013e3181cdde04.

PMID:
20118789
24.

Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review.

Palomaki GE, Bradley LA, Douglas MP, Kolor K, Dotson WD.

Genet Med. 2009 Jan;11(1):21-34. doi: 10.1097/GIM.0b013e31818efd77. Review.

25.

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO; EGAPP Working Group.

Genet Med. 2009 Jan;11(1):3-14. doi: 10.1097/GIM.0b013e318184137c.

26.
27.

Supplemental Content

Loading ...
Support Center